ADC Therapeutics SA (NYSE:ADCT)
| 2.28 Delayed Data As of May 26 |  -0.03 / -1.30%Today’s Change | 1.85 Today|||52-Week Range 10.88 | -40.62% Year-to-Date |
Latest ADCT News | Press Releases
No recent news for ADC Therapeutics SA.
Today’s Trading
| Previous close | 2.31 |
| Today’s open | 2.32 |
| Day’s range | 2.27 - 2.32 |
| Volume | 232,306 |
| Average volume (3 months) | 529,514 |
| Market cap | $183.9M |
Data as of 3:59pm ET, 05/26/2023
Growth & Valuation
| Earnings growth (last year) | +33.49% |
| Earnings growth (this year) | -30.73% |
| Earnings growth (next 5 years) | +16.95% |
| Revenue growth (last year) | +518.89% |
| P/E ratio | NM |
| Price/Sales | 1.43 |
| Price/Book | 2.07 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | August 22, 2023 |
| EPS forecast (this quarter) | -$0.69 |
| Annual revenue (last year) | $209.9M |
| Annual profit (last year) | -$155.8M |
| Net profit margin | -74.22% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
